Cardinal Health, Inc. – Consensus Indicates Potential -1.5% Downside

DirectorsTalk Interviews

Cardinal Health, Inc. with ticker code (CAH) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 80 and 56 and has a mean target at 69.54. With the stocks previous close at 70.63 this would indicate that there is a downside of -1.5%. The day 50 moving average is 62.01 while the 200 day moving average is 56.08. The market cap for the company is $19,046m. Visit the company website at: https://www.cardinalhealth.com

The potential market cap would be $18,752m based on the market concensus.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Share on:
Find more news, interviews, share price & company profile here for:

    Ironveld Plc raises £900k to ramp-up production for larger offtakers (LON:IRON)

    Ironveld plc has successfully raised £900,000 to enhance its mining operations and meet rising demand for strategic metals, signaling robust shareholder confidence.

    Johnson Service Group hosts site visit at Crawley facility

    Johnson Service Group Plc (LON:JSG) is hosting a site visit at its new Crawley laundry facility, showcasing innovations in textile services for the HORECA sector.

    Real Estate Credit Investments reports NAV rise to 145.6p in May 2025

    Real Estate Credit Investments Limited (LON:RECI) announces its May 2025 Fact Sheet, detailing a £298m portfolio and a NAV increase to 145.6p.

    Hercules plc to announce Interim Results on 17 June 2025

    Hercules plc (LON:HERC), a key player in UK infrastructure and construction labor supply, will reveal its interim results on June 17, 2025.

    Fidelity China Special Situations (FCSS) Annual Financial Report 2025

    Fidelity China Special Situations delivers its strongest annual performance since 2021, increased its ordinary dividend by 25 per cent, and continued to narrow the share-price discount while maintaining a disciplined approach to gearing and costs

    Spotlight on Golden Matrix’s (GMGI) Raffle Powerhouses: RKings & Classics for a Cause

    Discover how Golden Matrix Group, Inc. (NASDAQ: GMGI) is transforming the gaming landscape with innovative raffle models, driving growth and engagement in FY2024.

      Search

      Search